COMPLIANCE WITH RECOMMENDATIONS OF THE URODYNAMIC SOCIETY(US) FOR STANDARDS OF EFFICACY FOR EVALUATION OF TREATMENT OUTCOMES IN URINARY INCONTINENCE (UI)

 

Authors:

E DeAntoni, F Daneshgari, RS Lee

   

Institution:

University of Colorado Health Sciences Center, Denver, Colorado, USA.

     

Conference:

ICS 2000 Tampere

       

Type:

Informally discussed posters

         

Category:

Other

                 

 

Introduction and Objective.

The  US published (1997) minimal standards to assess the efficacy of therapy for UI . The standards were developed by a US committee and were approved by American Urological Society. The US intended that clinical and basic science research studies in UI would adopt these standards and report their findings according to this format. The objective of our study was to evaluate compliance with these standards in recent UI research studies.

 

Methods.

A Medline search was conducted for all articles in which outcomes of treatment for UI were reported (Nov 1997 - October 1999). A table containing the minimal recommended standards was developed which included pre-treatment data on: (a) micturition history; (b) structured physical exam (PE); (c) neurological and vaginal exams; (c) micturition diary; (d) pad test; (e) urodynamic studies (UDS). Post-treatment data were recommended on the same categories (a-e) as well as Quality of Life (QOL), Uroflowmetry and post-void residual (PVR). The data reported in each article were extracted and compared to the recommended standards. Compliance rates for each data field was calculated by percentages for (a) the individual article and (b) overall compliance rate among all articles. Not all data standards appeared relevant to some studies, so the denominator varied.

 

Results.

A total of 45 articles that reported treatment for UI were selected. The treatments included various sling procedures, injectables, pharmacological treatments, and mechanical valves. The compliance rate for individual article ranges from 25% -65% of recommended data. Table below shows the overall compliance rate for each data field among all the reports.

 

Pre-treatment:

Compliance

MictHist

50%

P.E.

60%

NeuroEx

20%

VagEx

63%

Diary

30%

PadTest

25%

UDS

58%

 

Post-treatment

 

MictHist

27%

P.E. 63%

Diary

25%

PadTest

30%

UDS

12%

Uroflow

43%

PVR    

43%

QOL

15%

 

Conclusions.

We conclude that there is far less than optimal reporting of outcomes for treatment of UI per the recommendations of the Urodynamic Society. This low compliance makes standardized evaluation of treatment outcomes difficult if not impossible. Without the ability to standardize evaluation of published studies fair and objective comparisons cannot be made. Research in UI should be designed to accommodate national guidelines.